Abstract
Magnesium sulfate given to women before birth at <30 weeks' gestation reduces the risk of cerebral palsy in their children. Our study aimed to assess the impact of a local quality improvement programme, primarily using plan-do-study-act cycles, to increase the use of antenatal magnesium sulfate. After implementing our quality improvement programme, an average of 86% of babies delivered at <30 weeks' gestation were exposed to antenatal magnesium sulfate compared with a historical baseline rate of 63%. Our study strengthens the case for embedding quality improvement programmes in maternal perinatal care to reduce the impact of cerebral palsy on families and society.
| Original language | English |
|---|---|
| Pages (from-to) | F225-F227 |
| Number of pages | 3 |
| Journal | Archives of Disease in Childhood: Fetal and Neonatal Edition |
| Volume | 107 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Mar 2022 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:©
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- health services research
- neonatology
Fingerprint
Dive into the research topics of 'Antenatal magnesium sulfate to prevent cerebral palsy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver